全文获取类型
收费全文 | 183080篇 |
免费 | 1620篇 |
国内免费 | 22篇 |
专业分类
耳鼻咽喉 | 1217篇 |
儿科学 | 6940篇 |
妇产科学 | 3175篇 |
基础医学 | 17653篇 |
口腔科学 | 1935篇 |
临床医学 | 13106篇 |
内科学 | 32287篇 |
皮肤病学 | 844篇 |
神经病学 | 17141篇 |
特种医学 | 9158篇 |
外科学 | 30052篇 |
综合类 | 2420篇 |
一般理论 | 6篇 |
预防医学 | 18633篇 |
眼科学 | 2838篇 |
药学 | 9920篇 |
中国医学 | 646篇 |
肿瘤学 | 16751篇 |
出版年
2023年 | 123篇 |
2022年 | 185篇 |
2021年 | 390篇 |
2020年 | 226篇 |
2019年 | 292篇 |
2018年 | 22214篇 |
2017年 | 17546篇 |
2016年 | 19686篇 |
2015年 | 1111篇 |
2014年 | 1092篇 |
2013年 | 1092篇 |
2012年 | 7457篇 |
2011年 | 21443篇 |
2010年 | 19037篇 |
2009年 | 11713篇 |
2008年 | 19785篇 |
2007年 | 21965篇 |
2006年 | 802篇 |
2005年 | 2439篇 |
2004年 | 3582篇 |
2003年 | 4559篇 |
2002年 | 2686篇 |
2001年 | 488篇 |
2000年 | 614篇 |
1999年 | 334篇 |
1998年 | 279篇 |
1997年 | 260篇 |
1996年 | 146篇 |
1995年 | 147篇 |
1994年 | 144篇 |
1993年 | 107篇 |
1992年 | 159篇 |
1991年 | 206篇 |
1990年 | 235篇 |
1989年 | 197篇 |
1988年 | 151篇 |
1987年 | 144篇 |
1986年 | 114篇 |
1985年 | 119篇 |
1984年 | 79篇 |
1983年 | 74篇 |
1982年 | 56篇 |
1980年 | 81篇 |
1979年 | 66篇 |
1974年 | 73篇 |
1971年 | 58篇 |
1970年 | 63篇 |
1969年 | 56篇 |
1938年 | 60篇 |
1932年 | 57篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
991.
Hormone replacement therapy (HRT) is effective in suppressing postmenopausal symptoms and, in the past, many have claimed that it is cardioprotective. It was thought that the lower incidence of cardiovascular disease in premenopausal women was related to the cardioprotective effect of estrogen. Many of these studies were, however, observational studies. HRT alters many cardiovascular parameters, most beneficially. The mixed effect on these parameters make the overall result on cardiovascular risk difficult to predict. However, recent randomized, placebo-controlled trials have shown not only that HRT does not confer cardioprotection, but that it actually increases one's cardiovascular risk in the short term. Based on the current evidence, HRT should not be recommended in the hope that it will protect postmenopausal women against coronary heart disease. 相似文献
992.
Chronic allergic eye disease encompasses several disorders, but it is vernal keratoconjunctivitis (VKC) and atopic keratoconjunctivitis
(AKC) that have sight-threatening sequelae. T cells, eosinophils, and mast cells are all found in the conjunctiva, and are
thought to play a role in disease pathogenesis. Recently, the conjunctival epithelium has also been considered to play a key
role. New and effective therapeutic strategies for the future for these patients depend on achieving a greater understanding
of the roles and interactions of the cell populations in these sight-threatening disorders. 相似文献
993.
Tingxu Yan Lei Shang Mengshi Wang Chenning Zhang Xu Zhao Kaishun Bi Ying Jia 《Metabolic brain disease》2016,31(3):653-661
The aim of this study was to explore the neuroprotective effects of active compounds from Schisandra chinensis (Trucz.) Baill. (Magnoliaceae) against the D-galactose (D-gal)-induced neurotoxicity in rat. The Wistar rats were subcutaneously injected with D-gal (150 mg/(kg day)) for six weeks and orally administered with water extract or 95 % ethanol extract (partitioned with petroleum ether (PE), chloroform (CF), ethyl acetate (EA) and n-Butanol (NB), respectively) of the fruits of Schisandra chinensis simultaneously. The alteration of cognitive functions was assessed by using Morris water maze and Step-down type passive avoidance test. The results demonstrated that PE fraction was the most effective fraction to ameliorate cognitive deficits. Further biochemical examination indicated that PE could attenuate the activities decreasing of superoxide dismutase (SOD), catalase (CAT), the total antioxidant (T-AOC) induced by D-gal, and maintain the normal levels of glutathione (GSH), malondialdehyde (MDA) and nitric oxide (NO) in the serum, prefrontal cortex, striatum and hippocampus of the brain of related rat, selectively. Meanwhile, the compounds of PE fraction were also identified as mainly lignans, thus, these results suggest that lignans from the PE fraction of Schisandra chinensis represented a potential source of medicine for the treatment of the aging-associated neurodegenerative diseases. 相似文献
994.
Steven A. Wartman Patricia S. O’Sullivan Michele G. Cyr 《Journal of general internal medicine》1990,5(1):S59-S69
Residency programs consist of a range of activities involving service to patients and education of residents. The observation that a conflict exists between the service and education components of residency is widespread and has been used to explain many of the problems afflicting such programs today. The authors believe that the service/education conflict is a significant barrier to change in residency programs. A model is presented for residency education that reorganizes the service and education components. First, they present a broad overview of the conflict. Then they provide a brief historical perspective and comment on some of the current recommendations for residency programs. Next, they discuss how principles of adult learning relate to residency and propose a new model of residency that adheres more closely to these principles. Finally, the proposed model is presented in some detail and its implications are discussed. Only if the service and education components of residency are carefully delineated can residency programs adapt to the changing and growing needs of postgraduate medical education. 相似文献
995.
Marchiori César Leal Medeiros Diulian Muniz Severo-Silveira Lucas dos Santos Oliveira Gabriel Medeiros Thales Menezes de Araujo Ribeiro-Alvares João Breno Baroni Bruno Manfredini 《Sport Sciences for Health》2022,18(2):415-423
Sport Sciences for Health - Muscular responses to training programs with the Nordic hamstring exercise (NHE) have been widely investigated to understand its preventive effects on muscle strain... 相似文献
996.
The SWAL–QOL and SWAL–CARE Outcomes Tool for Oropharyngeal Dysphagia in Adults: III. Documentation of Reliability and Validity 总被引:3,自引:0,他引:3
McHorney CA Robbins J Lomax K Rosenbek JC Chignell K Kramer AE Bricker DE 《Dysphagia》2002,17(2):97-114
Advances in the measurement of swallowing physiologic parameters have been clinician-driven, as has the development of intervention
techniques to modify swallowing pathophysiology. However, a critical element to determining the success of such efforts will
be established by the patients themselves. We conceptualized, developed, and validated the SWAL–QOL, a 93-item quality-of-life
and quality-of-care outcomes tool for dysphagia researchers and clinicians. With 93 items, the SWAL–QOL was too long for practical
and routine use in clinical research and practice. We used an array of psychometric techniques to reduce the 93-item instrument
into two patient-centered outcomes tools: (1) the SWAL–QOL, a 44-item tool that assesses ten quality-of-life concepts, and
(2) the SWAL–CARE, a 15-item tool that assesses quality of care and patient satisfaction. All scales exhibit excellent internal-consistency
reliability and short-term reproducibility. The scales differentiate normal swallowers from patients with oropharyngeal dysphagia
and are sensitive to differences in the severity of dysphagia as clinically defined. It is intended that the standardization
and publication of the SWAL–QOL and the SWAL–CARE will facilitate their use in clinical research and clinical practice to
better understand treatment effectiveness as a critical step toward improving patients' quality of life and quality of care. 相似文献
997.
Community-acquired pneumonia (CAP) is common, costly, and clinically serious. Several national and international practice guidelines have been developed to promote more appropriate, cost-effective care for patients with CAP. This article compares and contrasts eight international practice guidelines for the management of CAP, describes the extent to which recommendations are reflected in practice, and proposes explanations for non-adherence to guidelines. We found consistency in recommendations across all the guidelines for the management of patients with CAP requiring intensive care. In this setting, all guidelines recommend chest radiography, sputum Gram stain and culture, blood cultures, testing for Legionella pneumophila, and timely administration of antibiotics active against both typical (i.e. Streptococcus pneumoniae, Hemophilus influenzae) and atypical organisms (i.e. Legionella spp., Mycoplasma pneumoniae, and Chlamydia pneumoniae). Recommendations for the management of the average inpatient with pneumonia were more variable, with the greatest differences between the North American and European guidelines. The North American guidelines (in contrast to European ones), recommended empiric treatment of typical and atypical organisms in all inpatients. There were also differences in policies regarding the necessity of chest radiography, sputum studies, and serologic testing. Some guidelines explicitly embrace the use of prediction rules to inform the decision to hospitalize, while others do not. Some of these admission decision algorithms focus on identifying low risk patients, while others are most concerned with high risk patients. There was also considerable variation in the specificity and operationalization of clinical criteria for switching from parenteral to oral antibiotics or judging appropriateness for discharge. Many recommendations for key management decisions tended to lack explicit, objective, and actionable criteria that could be easily implemented in real world practice. Review of the pneumonia literature revealed that physician performance of guideline-recommended best practices is often suboptimal. Administration of timely antibiotics (< or =8 hours of presentation) and use of first-line antibiotics occurred in 75-85% and 18-79% of cases, respectively. Collection of blood cultures within 24 hours of presentation and prior to administration of antibiotics was achieved in 69-83% and 63-82% of cases, respectively. Screening the eligibility of CAP patients for hospital-based pneumococcal and influenza vaccination occurred on average in 11 and 14% of hospitalizations, respectively, in the US. Lack of awareness of guidelines, conflicting advice among them, and lack of specific, objective, actionable recommendations most likely contribute to nonadherence to CAP guidelines. Increased attention to these factors will be needed if professional society practice guidelines are to fulfill their promise as tools for improving the quality and outcomes of care for patients with pneumonia. 相似文献
998.
999.
Lifeng Lin Haitao Chu Mohammad Hassan Murad Chuan Hong Zhiyong Qu Stephen R. Cole Yong Chen 《Journal of general internal medicine》2018,33(8):1260-1267
Background
Decision makers rely on meta-analytic estimates to trade off benefits and harms. Publication bias impairs the validity and generalizability of such estimates. The performance of various statistical tests for publication bias has been largely compared using simulation studies and has not been systematically evaluated in empirical data.Methods
This study compares seven commonly used publication bias tests (i.e., Begg’s rank test, trim-and-fill, Egger’s, Tang’s, Macaskill’s, Deeks’, and Peters’ regression tests) based on 28,655 meta-analyses available in the Cochrane Library.Results
Egger’s regression test detected publication bias more frequently than other tests (15.7% in meta-analyses of binary outcomes and 13.5% in meta-analyses of non-binary outcomes). The proportion of statistically significant publication bias tests was greater for larger meta-analyses, especially for Begg’s rank test and the trim-and-fill method. The agreement among Tang’s, Macaskill’s, Deeks’, and Peters’ regression tests for binary outcomes was moderately strong (most κ’s were around 0.6). Tang’s and Deeks’ tests had fairly similar performance (κ?>?0.9). The agreement among Begg’s rank test, the trim-and-fill method, and Egger’s regression test was weak or moderate (κ <?0.5).Conclusions
Given the relatively low agreement between many publication bias tests, meta-analysts should not rely on a single test and may apply multiple tests with various assumptions. Non-statistical approaches to evaluating publication bias (e.g., searching clinical trials registries, records of drug approving agencies, and scientific conference proceedings) remain essential.1000.